Form D — NexPoint Life Sciences III DST
0002008210-25-000003 · filed Apr 18, 2025
Offering
- Industry
- Other Real Estate
- Exemptions
- 06c, 3C, 3C.1, 3C.5
- Total offering
- $30,661,253
- Total sold
- $11,537,013
- Minimum investment
- $100,000
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NexPoint Life Sciences III DST
- CIK
- 2008210
- Entity
- Other
- Jurisdiction
- DELAWARE
- Year incorporated
- 2023
- Address
- 300 CRESCENT COURT
DALLAS, TX 75201 - Phone
- (833) 697-6246
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
N/A NexPoint Real Estate Advisors IV, L.P. · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Brian Mitts · Executive OfficerDallas, TX Find on LinkedIn ↗
-
Matt McGraner · Executive OfficerDallas, TX Find on LinkedIn ↗
-
N/A NREA LS III Manager, LLC · Executive OfficerDallas, TX Find on LinkedIn ↗
-
N/A NREA LS III Contributor, LLC · Executive OfficerDallas, TX Find on LinkedIn ↗
View the original filing on SEC EDGAR ↗